
Changing the Game in Drug Development Brochure
At Certara, we are innovators, dedicated to helping our clients develop new therapies and target unmet medical needs, expand existing therapies to other subpopulations, communicate scientific information in the language of regulatory success and market access, balance risk-benefit profiles, differentiate therapies from the competitive landscape, and unlock millions of dollars in R&D savings.

Pharmacokinetic/ Toxicokinetic Services Brochure
As your partner for drug development and regulatory strategy, Certara has expanded its services to offer GLP-compliant pre-clinical PK/TK NCA analysis and reporting.

Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study On-Demand Webinar
This webinar introduced how IVIVC can be used to get your drug program back on track! Learn how to analyze a failed BE study and use IVIVC to explore better dissolution tests, predict your target dissolution to meet the reference, and optimize your drug's formulation.

How to Use a Reference-scaled Average Bioequivalence Approach for Narrow Therapeutic Index Drugs On-Demand Webinar
Watch this webinar to learn how RSABE for NTIDs can be performed in Phoenix WinNonlin using a reusable template.